Dickerson, R.N.; Turner, S.C.; Holmes, W.L.; Van Matre, E.T.; Swanson, J.M.; Byerly, S.; Filiberto, D.M.; Fischer, P.E.
Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients. Nutrients 2022, 14, 1650.
https://doi.org/10.3390/nu14081650
AMA Style
Dickerson RN, Turner SC, Holmes WL, Van Matre ET, Swanson JM, Byerly S, Filiberto DM, Fischer PE.
Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients. Nutrients. 2022; 14(8):1650.
https://doi.org/10.3390/nu14081650
Chicago/Turabian Style
Dickerson, Roland N., Stephen C. Turner, Whitney L. Holmes, Edward T. Van Matre, Joseph M. Swanson, Saskya Byerly, Dina M. Filiberto, and Peter E. Fischer.
2022. "Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients" Nutrients 14, no. 8: 1650.
https://doi.org/10.3390/nu14081650
APA Style
Dickerson, R. N., Turner, S. C., Holmes, W. L., Van Matre, E. T., Swanson, J. M., Byerly, S., Filiberto, D. M., & Fischer, P. E.
(2022). Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients. Nutrients, 14(8), 1650.
https://doi.org/10.3390/nu14081650